Original Article
  

The Changes of Th17/Treg and Related Cytokines: IL-17, IL-23, IL-10, and TGF-β in Respiratory Syncytial Virus Bronchiolitis Rat Model

Abstract

Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and hospitalization that lead to high morbidity and mortality among young infants. T helper 17 (Th17) cells and regulatory T cells (Tregs) play essential roles in the pathogenesis of autoimmune, cancer, and inflammatory diseases. However, whether changes in T-cell subsets are related to the systemic immune responses in RSV-caused bronchiolitis merit further investigation. Three-week-old Sprague Dawley (SD) rats were randomly divided into the normal control (NC) and RSV bronchiolitis (RSV-B) groups. An RSV-B model was successfully established using nasal drip containing RSV. Furthermore, pathological changes in the lung tissues were observed using hematoxylin and eosin staining. Flow cytometry determined the levels of Th17 and Treg subsets. The related cytokines were measured using enzyme-linked immunosorbent assay (ELISA). The expression levels of related transcription factors, such as RORγt and FOXP3, were examined using real-time quantitative PCR and western blot analysis. The RSV-B group exhibited pulmonary interstitial hyperemia and edema, inflammatory cell infiltration, wide alveolar septa, and bronchial collapse and deformation. The percentage of Th17 cells in RSV-B group was about 2.3 fold higher than that of NC group, and the concentration of IL-17, IL-23 and RORγt was higher than in NC group. In contrast, the percentage of Treg cells in the RSV-B group was approximately 0.7 fold lower than that in the NC group, and the levels of IL-10, TGF-β, and FOXP3 in the RSV-B group were lower than those in the NC group. The above results were statistically significant. The changes of Th17/Treg, and their associated cytokines, specific transcription factors, are present in RSV bronchiolitis model rats, which may play an important role in the pathogenesis of RSV bronchiolitis. 

  1. Meng J SC, Hotard AL, Moore ML. An overview of respiratory syncytial virus. PLoS Pathog 2014; 10(4):e1004016.
  2. Hall CB SE, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol 2013; 372:39-57.
  3. 3Hall CB WE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991; 163(4):693-8.
  4. Simoes EA C-EX, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. The effect of respiratory syncytial virus
    on subsequent recurrent wheezing in atopic and
    nonatopic children. J Allergy Clin Immunol 2010; 126(2):256-62.
  5. Hall CB WG, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360(6):588-98.
  6. Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003; 168(6):633-9.
  7. Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 2006; 117(5):e878-86.
  8. Lambert L, Sagfors AM, Openshaw PJ, Culley FJ. Immunity to RSV in Early-Life. Front Immunol 2014; 5:466.
  9. Graham BS. Vaccine development for respiratory syncytial virus. Curr Opin Virol 2017; 23:107-112.
  10. Jiao YY, Fu YH, Yan YF, Hua Y, Ma Y, Zhang XJ, et al. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus. Antiviral Res 2017; 144:57-69.
  11. Jorquera PA, Anderson L, Tripp RA. Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis. Expert Rev Vaccines 2016; 15(2):173-87.
  12. Mangodt TC, Van Herck MA, Nullens S, Ramet J, De Dooy JJ, Jorens PG, et al. The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res 2015; 78(5):483-91.
  13. Cosmi L LF, Maggi E, Romagnani S, Annunziato F. Th17 cells: newplayers in asthma pathogenesis. Allergy 2011; 66(8):989-98.
  14. Bettelli E KT, Oukka M, Kuchroo VK. Induction and effector functions of T(H)17 cells. Nature 2008; 453(7198):1051–7.
  15. Iwakura Y IH, Saijo S, Nakae S. Functional specialization ofinterleukin-17 family members. Immunity 2011; 34(2):149-62.
  16. Ohkura N KY, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity 2013; 38(3):414-23.
  17. . Rudensky A Y: Regulatory T cells and Foxp3[J]. Immunological reviews 2011; 241: 260-268.
  18. Kearley J RD, Lloyd CM. CD4+CD25+ regulatory T cells reverseestablished allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 2008; 122(3):617-24.
  19. Tao B RG, Wang D, Li Y, Wang Z, Yin G. Imbalance of Peripheral Th17 and Reg SourceSO 2015 Jun 14 3 273 9[PMIDT26546895].pdf>. Iran J Allergy Asthma Immunol 2015; 14(3):273-9.
  20. Mukherjee S, Lindell DM, Berlin AA, Morris SB, Shanley TP, Hershenson MB, et al. IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease. Am J Pathol 2011; 179(1):248-58.
  21. Pickles R J, DeVincenzo J P: Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis[J]. J Pathol 2015; 235: 266-276.
  22. Byington CL WJ, Korgenski K, Sheng X. Respiratory Syncytial Viru-Associated Mortality in Hospitalized Infants and Young Children. Pediatrics 2015; 135(1):e24-e31.
  23. Turner TL KB, Paul G, Landgrave LC, Hayes D Jr, Thompson R. Respiratory syncytial virus: current and emerging treatment options. Clinicoecon Outcomes Res 2014; 6:217-25.
  24. Wakashin H HK, Maezawa Y, Kagami SI, Suto A, Watanabe N, Saito Y, Hatano M,Tokuhisa T, Iwakura Y, Puccetti P, Iwamoto I, Nakajima H: IL-23 and Th17 cells enhance Th2 cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008; 178(10):1023-32.
  25. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17．J Exp Med 2008; 205(2):385-93．
  26. Wakeland EK. Hunting autoimmune disease genes in NOD: Early steps on a long road to somewhere important (hopefully). J Immunol 2014; 193(1):3-6.
  27. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8(9):950-7.
  28. Ferraro A, Socci C, Stabilini A, Valle A, Monti P, Piemonti L, et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 2011; 60(11):2903-13．.
  29. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-β and inductionnof the nuclear receptor RORγt. Nat Immunol 2008; 9(6):641-9.
  30. Lee WW1, Kang SW, Choi J, Lee SH, Shah K, Eynon EE, et al. Regulating human Th17 cells via differential expression of IL-1 receptor[J]. Blood 2010; 115(3):530-40.
  31. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126(6):1121-33.
  32. Liston A,Gray DH, Homeostatic control of regulatory T cell diversity[J].Nat Rev Immunol.2014 14(3):154-65
  33. Kearley J,Robinson DS, Lloyd CM. CD4+CD25+ regulatory T cells reverseestablished aleergic airway inflammation and prevent airway remodeling[J].J Allergy Clin Immunol. 2008;122:617-624.
  34. Joetham A, Takeda K, Taube C, Miyahara N, Matsubara S, Koya T, et al. Naturally occurring lung CD4+ CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β[J]. J Immunol 2007; 178(3):1433-42.
  35. Kim HP,Leonard WJ. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med.2007 204(7):1543-51.
  36. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Rückert B, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 2007; 5(12):e329.
  37. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326(5955):986-91.
  38. Torgerson TR, Ochs HD. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells[J]. J Allergy Clin Immunol 2007; 120(4):744-50.

Files
IssueVol 16, No 5 (2017) QRcode
SectionOriginal Article(s)
Keywords
Bronchiolitis Th17 cells regulatory T cells Respiratory syncytial virus
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Gao M, Liu L-X, Wu F-L, Zhang X, Li Y-Y, Shi T, Li D-Z, Han T-T. The Changes of Th17/Treg and Related Cytokines: IL-17, IL-23, IL-10, and TGF-β in Respiratory Syncytial Virus Bronchiolitis Rat Model. Iran J Allergy Asthma Immunol. 2017;16(5):386-395.